 HANOVER, MD., May 07, 2021 GLOBE NEWSWIRE -- Processa Pharmaceuticals, Inc. NASDAQ: PCSA, Processa or the Company, a clinical-stage biopharmaceutical company developing products to improve the survival andor quality of life for patients who have unmet medical needs, today announces it will host a conference call and live webcast on May 13, 2021, at 5:30 p.m. EST to discuss its first quarter 2021 results and provide an update on the Companys clinical pipeline. 